Chronic liver disease — including cirrhosis linked to hepatitis B, hepatitis C, and non-alcoholic fatty liver disease — is a growing health concern in Kenya, where viral hepatitis remains under-diagnosed in many counties outside Nairobi. For many Kenyan patients, liver transplant is either unavailable locally or involves long waiting times and high private-hospital costs. Stem Cell Cure India works with Kenyan patients exploring stem cell therapy as a treatment option that may help support liver function without the need for a full transplant.
Liver transplant capacity in Kenya remains limited to a small number of private hospitals in Nairobi, with significant cost and long waiting periods for compatible donors. Many patients are referred abroad — commonly to India — for both transplant and non-transplant treatment options. Stem cell therapy is increasingly considered by Kenyan patients and their doctors as an option to explore before, or instead of, transplant, particularly in earlier or moderate stages of liver disease.
Dr. Tyagi leads the regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients — including those travelling from Kenya for chronic liver disease treatment.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients — including baseline assessments for liver disease patients — before and during their stem cell therapy journey at Stem Cell Cure India.
Mesenchymal Stem Cells (MSCs), typically sourced from bone marrow or umbilical cord tissue, are studied for their potential to support liver tissue repair, reduce inflammation, and improve markers of liver function. The cells are administered via a minimally invasive procedure — most often through an intravenous or targeted infusion — under the supervision of our hepatology and regenerative medicine team. This approach does not replace the need for a donor organ in advanced end-stage disease, but may help support liver function and quality of life in suitable candidates.
Suitability depends on the stage and cause of liver disease. Before travelling, our team reviews:
No. Stem cell therapy is not a replacement for transplant in advanced end-stage liver failure. It is explored as an option to help support liver function, particularly in earlier or moderate-stage disease, and should be discussed alongside — not instead of — standard hepatology care.
Patients with active viral hepatitis are evaluated carefully before treatment. In many cases, antiviral management is addressed as part of the overall care plan alongside stem cell therapy. Our team will review your hepatitis status as part of the pre-screening process.
Recent liver function tests (LFTs), abdominal ultrasound or CT/MRI, hepatitis B/C status, and any prior treatment history. This allows our team to give an initial opinion before you commit to travel.
Most patients stay between 7 and 14 days, depending on the diagnostic work-up required and the treatment plan. We will confirm an exact timeline after reviewing your reports.
Yes. Once treatment is confirmed, we provide the invitation and supporting documents Kenyan citizens need to apply for a Medical Visa through the Indian High Commission in Nairobi.
Cost depends on disease stage and the treatment plan required. Contact us for a personalised quote after sharing your liver function reports and medical history.
"Stem Cell Cure (P) Ltd." deals in the following servies:-
| General Medical/Surgical Treatment | Stem Cell Treatment for Degenerative Diseases |
|---|---|
| Bariatric surgery | Neuro-Applications 1. Brain Stroke/Injury |
| Cardiology | 2. Spinal Cord Injury |
| Cardiothoracic surgery | 3. Spinal Fusion |
| Colorectal surgery | 4. Autism |
| Drug and alcohol services | 5. Cerebral Palsy |
| Ear, nose & throat (ENT) | 6. Motor Neuron Disease(ALS, PBP) |
| Gastroenterology | 7. Multiple Sclerosis (MS) |
| General surgery | Ortho- Applications 1. Knee Cartilage Defect or arthritis |
| Gynaecology | 2. Hip Avascular Necrosis/Osteonecrosis |
| Haematology | 3. Rheumatoid Arthritis |
| Internal medicine | 4. Non-Union Fracture/Delayed Union |
| Mental Health | Vascular Applications 1. Coronary Arterial Disease |
| Neurology | 2. Peripheral Arterial Disease such as CLI |
| Neurosurgery | 3. Diabetic Foot ulcer/Gangrene |
| Obstetrics, gynaecology and IVF | Eye related Application 1. Optic Nerve Damage |
| Oncology / cancer | 2. Retinitis Pigmentosa |
| Oral and Maxillo surgery | 3. Macular Degeneration |
| Orthopaedic (Knee/Hip) surgery | Other Applications 1. Diabetes |
| Paediatric surgery | 2. Acute/Chronic kidney disease |
| Physicians | 3. Acute/Chronic Liver disease |
| Plastic & reconstructive surgery | 4. Acute/Chronic Lung disease |
| Rehabilitation | 5. Muscular Dystrophy as DMD & SMA |
| Renal | 6. Myocardial Infarction (MI) |
| Respiratory medicine | 7. Hair Regeneration |
| Urology | 8. Blood related cancer treatment |
| Vascular surgery | 9. Anti-aging |
| Dentisity |
